Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (Text with EEA relevance. )
Allegato 1ANNEX
In vigore · versione del 23 gen 2018
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) in the sixth column, expiration of approval, of row 54, Propineb, the date is replaced by ‘31 January 2019’;
(2) in the sixth column, expiration of approval, of row 55, Propyzamide, the date is replaced by ‘31 January 2019’;
(3) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2019’;
(4) in the sixth column, expiration of approval, of row 58, Propiconazole, the date is replaced by ‘31 January 2019’;
(5) in the sixth column, expiration of approval, of row 77, Zoxamide, the date is replaced by ‘31 January 2019’;
(6) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2019’;
(7) in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by ‘31 January 2019’;
(8) in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by ‘31 January 2019’;
(9) in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2019’;
(10) in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2019’;
(11) in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2019’;
(12) in the sixth column, expiration of approval, of row 121, Clothianidin, the date is replaced by ‘31 January 2019’;
(13) in the sixth column, expiration of approval, of row 122, Pethoxamid, the date is replaced by ‘31 January 2019’;
(14) in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2019’;
(15) in the sixth column, expiration of approval, of row 277, Copper compounds, the date is replaced by ‘31 January 2019’.